Form EFFECT Calidi Biotherapeutics,
Tweet
Share
E-mail| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | February 7, 2025 5:00 P.M. |
| Form: | S-3 | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Preliminary data on early redemptions (prepayments)
- LEADING EDGE MATERIALS ANNOUNCES C$ 6,000,000 NON-BROKERED PRIVATE PLACEMENT WITH BINDING STANDBY SUBSCRIPTION AND COMMITMENT OF CORNERSTONE SHAREHOLDER
- Huhtamaki publishes 2026 Half-Yearly Report on July 23, 2026
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
